Chemomab Therapeutics Q4 EPS $(0.26) Up From $(0.72) YoY

Moomoo 24/7 ·  Mar 7 07:06

Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.26) per share. This is a 63.89 percent increase over losses of $(0.72) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment